While the IGBB Service Center can perform low-risk, fairly routine biomolecular tasks on a fee-per-service basis, some of your research goals may require (or would most readily be completed with) the help of professionals trained in advanced procedures and/or data analysis techniques. The IGBB research associates, most of whom have Ph.D. degrees and/or many years of practical experience, can be hired to conduct research tasks associated with their specialties. For example, let's say you need an expert in RNA isolation and RNAseq to help you complete a portion of a research project. You could train a student or postdoc to become proficient in these research tasks, but you may not have the experience, time, or money to train someone. Moreover, you may not have the instrumentation you need to do the research correctly. This is where the IGBB can help. Rather than training someone new, you can hire a highly skilled IGBB scientist to perform the research for you. The savings in cost and time is tremendous! The process works like this:
- The principal investigator (PIs) interested in determining whether
the IGBB can help them in their research/analyses contacts one of the IGBB's Research Leads.
- The Research Lead(s) sets up a meeting with the PI to discuss project goals, feasibility, and
approaches. This consultation is free.
- If the PI and the Research Lead agree to a research plan, the
Research Lead
will generate an itemized quote for the PI that includes salary, fringe, reagent
costs, machine costs, etc. The duration of the employment agreement depends upon the needs of the customer and can range from a few hours to several months. In addition, IGBB employment agreements can cover fairly low weekly time committments spread out over long stretches (e.g., a customer may hire an IGBB employee to work on a project 5 hours a week for four years). Overhead charges and/or HPC² retainage costs may or may not be
applicable. Once a plan is set between a PI and an IGBB Research Lead, a final quote will be sent to the PI for approval. Once the PI approves the quote, work can begin.
If you don't have funding in hand, but are working on a grant proposal, you can include the participation of an IGBB expert-for-hire in your proposal budget (note: you must make such agreements with the expert-for-hire through a IGBB itemized quote). To discuss a hiring an IGBB expert, please contact one of the IGBB's Research Leads by phone or e-mail.
NOTE: PIs are asked to consider whether the participation of an IGBB employee in a project merits that employee's inclusion as a co-author on a resulting manuscript(s). The decision ultimately lies with the PI. However, the IGBB encourages IGBB staff and faculty involved in
Proposal Partnerships and
Experts for Hire to discuss/negotiate co-authorship with PIs before starting work on a project.

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
IGBB Authors:
Natàlia Garcia-ReyeroPUBLICATION YEAR:
2014IMPACT FACTOR:
2.624CITATION COUNT:
330Tollefsen KE, Scholz S, Cronin MT, Edwards SW, de KJ, Crofton K, Garcia-Reyero N, Hartung T, Worth A, Patlewicz G (2014) Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).
Regulatory Toxicology & Pharmacology 70(3): 629-640.
DOI:
10.1016/j.yrtph.2014.09.009EID:
2-s2.0-84922433050PMID: 25261300
DOWNLOAD PDFABSTRACTChemical regulation is challenged by the large number of chemicals requiring assessment for potential human health and environmental impacts. Current approaches are too resource intensive in terms of time, money and animal use to evaluate all chemicals under development or already on the market. The need for timely and robust decision making demands that regulatory toxicity testing becomes more cost-effective and efficient. One way to realize this goal is by being more strategic in directing testing resources; focusing on chemicals of highest concern, limiting testing to the most probable hazards, or targeting the most vulnerable species. Hypothesis driven Integrated Approaches to Testing and Assessment (IATA) have been proposed as practical solutions to such strategic testing. In parallel, the development of the Adverse Outcome Pathway (AOP) framework, which provides information on the causal links between a molecular initiating event (MIE), intermediate key events (KEs) and an adverse outcome (AO) of regulatory concern, offers the biological context to facilitate development of IATA for regulatory decision making. This manuscript summarizes discussions at the Workshop entitled "Advancing AOPs for Integrated Toxicology and Regulatory Applications" with particular focus on the role AOPs play in informing the development of IATA for different regulatory purposes.
The IGBB is supported, in part, by the following units:
The IGBB is an HPC² member center.